Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone; D011565:Psoriasis / Q000188:drug therapy / Q000503:physiopathology*; D012867:Skin / Q000098:blood supply; D014661:Vasoconstriction / Q000187:drug effects*
D000893:Anti-Inflammatory Agents; D001623:Betamethasone; D001624:Betamethasone Valerate; D006854:Hydrocortisone